The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $73.75

Today's change-0.40 -0.54%
Updated May 29 4:07 PM EDT. Delayed by at least 15 minutes.
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $73.75

Today's change-0.40 -0.54%
Updated May 29 4:07 PM EDT. Delayed by at least 15 minutes.

St. Jude Medical Inc down (U.S.)$0.40

St. Jude Medical Inc closed lower Friday, dropping (U.S.)$0.40 or 0.54% to (U.S.)$73.75. Shares have lost 0.70% over the last five days, but sit 2.61% below their 52-week high. This security has outperformed the S&P 500 by 3.88% during the last year.

Key company metrics

  • Open(U.S.) $74.12
  • Previous close(U.S.) $74.15
  • High(U.S.) $74.28
  • Low(U.S.) $73.49
  • Bid / Ask-- / --
  • YTD % change+13.41%
  • Volume1,834,866
  • Average volume (10-day)1,156,807
  • Average volume (1-month)1,429,795
  • Average volume (3-month)1,756,726
  • 52-week range(U.S.) $54.80 to (U.S.) $75.73
  • Beta1.35
  • Trailing P/E21.01×
  • P/E 1 year forward18.68×
  • Forward PEG2.39×
  • Indicated annual dividend(U.S.) $1.16
  • Dividend yield1.57%
  • Trailing EPS(U.S.) $3.51
Updated May 29 4:07 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.34%

Based on its net profit margin of 17.34%, St. Jude Medical Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.62%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 04, 201504/04/2015Jan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue1,3451,4391,3721,448
Total other revenue--------
Total revenue1,3451,4391,3721,448
Gross profit9521,0199841,041
Total cost of revenue393420388407
Total operating expense1,0201,1591,1021,159
Selling / general / administrative430378461492
Research & development167175169178
Depreciation / amortization2489----
Interest expense (income), net operating--------
Unusual expense (income)6978482
Other operating expenses, total--------
Operating income325280270289
Interest income (expense), net non-operating-21-22-21-21
Gain (loss) on sale of assets--------
Other--------
Income before tax308258250268
Income after tax256238232246
Income tax, total52201822
Net income262245238270
Total adjustments to net income--------
Net income before extra. items262245238270
Minority interest67624
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items262245238270
Inc. avail. to common incl. extra. items262245238270
Diluted net income262245238270
Dilution adjustment--00--
Diluted weighted average shares287291290289
Diluted EPS excluding extraordinary itemsvalue per share0.910.840.820.93
Dividends per sharevalue per share0.290.270.270.27
Diluted normalized EPSvalue per share0.931.151.091.20